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Abstract 
An implicit aim in cellular infection biology is to understand the mechanisms how 
viruses, microbes, eukaryotic parasites, and fungi usurp the functions of host cells and 
cause disease. Mechanistic insight is a deep understanding of the biophysical and 
biochemical processes that give rise to an observable phenomenon. It is typically 
subject to falsification, that is, it is accessible to experimentation and empirical data 
acquisition. This is different from logic and mathematics, which are not empirical, but 
built on systems of inherently consistent axioms. Here, we argue that modeling and 
computer simulation, combined with mechanistic insights, yields unprecedented deep 
understanding of phenomena in biology, and especially in virus infections by providing a 
way of showing sufficiency of a hypothetical mechanism. This ideally complements the 
necessity statements accessible to empirical falsification by additional positive 
evidence. We discuss how computational implementations of mathematical models can 
assist and enhance the quantitative measurements of infection dynamics of enveloped 
and non-enveloped viruses, and thereby help generating causal insights into virus 
infection biology.  
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Introduction 
Viruses are known to infect all forms of life. They are the most ubiquitous entities on 
earth, exceeding 1030 particles, most of them bacteriophages. Viruses are multi-facetted 
entities at the nanoscale or microscale. They have a dual nature, the virus particle –  
virion, and the virus – the infected cell. Virions come in many shapes and sizes ranging 
from regular icosahedral particles to membrane-enwrapped amorphous entities. All 
viruses carry a ribonucleic acid (RNA) or deoxy-ribonucleic acid (DNA) genome, and 
encode their own replicases, which normally lack proof-reading activity, in contrast to 
cellular DNA or RNA polymerases. Error-prone replication together with genetic 
recombination and genomic re-assortment give rise to clouds of genetically related, but 
not identical viral genomes that, when packaged into particles, give rise to a so-called 
quasi-species of virus genomes [1-3]. This illustrates the notion that viruses act as an 
ensemble drawn from a cloud of related genome sequences. This is the fundamental 
basis for virus evolution under selection pressure, when viruses are exposed to a 
changing environment, for example when they infect a new host organism or cell type, 
or when they are under the pressure of chemicals or the immune system. 
Virions unconditionally require the assistance of a cell to produce their progeny. They 
are obligatory parasites. Virions have to enter into a cell in order to replicate and cause 
an infection. This requires that pre-existing cellular mechanisms assist virus infection. 
These mechanisms can be explored by studying viruses, using viruses also as a proxy 
for understanding host-cell biology. Viruses can cause disease or be cleared by the 
immune system. In fact, most viruses on earth are not pathogenic to humans, since the 
immune system protects against foreign agents, and many viral agents simply have not 
coevolved with humans. However, virus infection dynamics is complex, which is 
reflected in the long-standing and wide-spread observation that not all cells and 
individuals become equally infected when exposed to the same amount of virions. 
To understand how viruses cause disease, quantitative measurements of infection 
processes were developed that make use of genetic interference, specific drugs, and 
the expression of dominant-negative proteins that mimic a particular host-cell function. 
A classical procedure to understand mechanisms in cell and infection biology has been 
to use bottom-up reconstitution experiments to partially rebuild or reconstitute a certain 
cellular function from scratch. This comprised, for example, the actin network, the 
microtubule spindle, centriolar assemblies, the nuclear envelope, the endoplasmic 
reticulum, T-cell receptor signaling, and the motility of organelles on cytoskeletal tracks 
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[4]. Insights from such experiments have allowed us to reconstitute cellular processes 
and structures by using a small set of components from cell extracts. But, even if there 
is an inventory available of the proteins and factors used in a given reconstitution, and 
even if we know the biophysical properties of all components, we still do not understand 
many of the cell-based processes leading to infection until we know how these 
components interact with each other. This has been realized early on in the fields of cell 
motility and cell division, where both the inventory and the biophysics of many of the 
underlying components have been successfully combined into bottom-up in vitro 
systems, reproducing some key aspects of cell migration and division [5,6]. What is 
necessary for a system-wide analysis is that the biophysical and mechanical properties 
of the components are integrated into a new experimental entity to gain a more 
comprehensive and realistic understanding of the interaction mechanisms of infection 
processes.  
Computational modeling and simulation can provide such an experimental entity, where 
mechanisms and interaction processes are reconstituted in silico in a fully controlled 
way. Experiments are then conducted computationally in what is called a “simulation”. 
Increasingly important aspects of infection dynamics are therefore addressed by 
mathematical and computational modeling [for a review, see 7]. This is particularly 
interesting, as it allows to estimate otherwise hidden infection parameters. This can be 
done in the context of an immune response or a secondary bacterial infection in the 
respiratory tract, for example Streptococci and Staphylococci co-infections with 
Influenza A virus (IAV) [8,9]. IAVs include seasonal human influenza viruses, and are 
found to circulate in wild water birds. They are highly transmissible, and are estimated 
to cause several hundreds of thousands of deaths per year [10]. Notably, the Spanish 
influenza pandemic had caused approximately 50 million deaths, and bacterial 
pneumonia was a main cause for the high lethality of the 1918 IAV pandemics [11,12]. 
However, up to now, the co-pathogenic mechanisms resulting in the high lethality of IAV 
and bacterial infections have remained unknown.  
We surmise that the development of mathematical modeling frameworks of bacterial 
and viral infections, as well as co-infections, will help integrate progressive immuno-
senescence and identify host genetic factors to advance the understanding of infectious 
disease to an unprecedented level of depth. In this review, we highlight some of the 
principles of computational modeling, and elaborate on examples for how to link in silico 
experiments with infection biology in order to enhance insight into mechanisms.  
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Enhancing information from cell imaging of viral infections 
Advances in microscopy techniques have proven indispensable to advance insights into 
virus infection mechanisms in all phases of the viral life cycle, including entry, 
replication, assembly and egress [13-16]. Fluorescence as well as luminescence 
imaging further provide new opportunities for bridging in vitro cell culture systems to in 
vivo applications, thus aiding our understanding of virus pathogenesis and early 
diagnosis of viral infection and development. Fluorescence virus imaging at high spatio-
temporal resolution and in super-resolution helps distinguish direct from indirect effects 
of anti-viral interference, for example in small-compound and RNA interference screens 
[17-19]. Additionally, imaging is powerful for tracking sub-viral entities, such as viral 
genomes, with bio-orthogonal click chemistry and for visualizing individual virion 
particles in cells, as pioneered with adenoviruses [20], and followed up with HIV [21,22].  
Advances in light microscopy have been accompanied by developments in 
computational image analysis. This first included high-accuracy single-particle tracking 
algorithms, used for example for analyzing infection dynamics of fluorescently labeled 
virions at the cellular scale [23]. Single-particle tracking of fluorescently labeled virions 
has become a standard method of analysis, typically followed by trajectory 
segmentation [24-26] or the calculation of motion descriptors, such as diffusion 
constants and Hurst exponents. This has led to the discovery of different viral motion 
types, which are diagnostic of the stage in the virus entry program [27,25,26,24,28]. 
When combined with nanometer-precision segmentations of intracellular organelles 
involved in virus entry, such as endosomes [29], imaging and tracking of individual 
virion particles enables spatial statistical studies of how virions position in a cell with 
respect to those structures. This can, for example, be used to derive interaction maps 
that explain the action of a drug or a genetic perturbation [30]. Furthermore, the 
development of state-of-the-art correlation techniques involving electron microscopy 
with nanometer-precision localization of components, and fluorescence microscopy with 
larger context of the infected cell has enhanced insights into virus morphogenesis with 
unprecedented ultra-structural detail [31]. 
A single high-resolution image of fluorescent virions already contains a lot of 
information. For example, spatial statistics, such as Ripley’s K-function, can be used to 
decide whether the virions are uniformly distributed, or clustered [32]. This provides 
direct evidence about their interactions, even if mediated by confounding factors. If a 
second color channel shows a host-cell structure of interest, such as endocytic 
compartments, a generalization of spatial statistics can be used to infer the most likely 
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interaction between the virions and the host-cell structure [30]. This type of analysis 
estimates an interaction potential that is most likely responsible for the observed 
distribution of virions with respect to the given distribution of host-cell structures. As still 
images suffice for these analyses, the procedure naturally applies to single-molecule 
localization modalities, such as PALM and STORM [33]. And, since the gradient of the 
estimated potential can be interpreted as a force, the expected dynamics of the virions 
can be estimated for the next time step, i.e., a single still image can be used to predict 
how the virions are likely to move in the next time instance.  
Mechanisms of infection 
The development and manifestation of infectious diseases is highly complex and 
involves host cells and pathogens in all possible combinations. Two principle types of 
approaches are used to analyze host-pathogen interactions: top-down and bottom-up. 
Top-down approaches describe the larger context of infectious disease phenotypes, 
and involve epidemiology, physiology, and omics measurements, including messenger 
RNAs, proteins, lipids, metabolites, and sugars at the level of an individual, an organ, or 
a particular cell type. When combined with microscopy, these measurements 
increasingly enable phenotypic profiling at the subcellular level, for example by using 
single RNA detection assays or imaging mass cytometry [34,35]. Methodological 
refinements further allow quantitative assessments and data correlation. 
To stringently support new concepts, mechanistic insights are, however, required. At the 
level of cells, a virus infection can be dissected into distinct steps, for which 
mechanisms can be elucidated [36,13,37]. These mechanisms can then be considered 
bottom-up, that is from their constituting biochemical and biophysical processes. For 
example, the mechanism by which a virus particle binds to cells involves one or several 
receptors that directly bind to the virus and hence initiate infection. In addition, binding 
of virions to cells may involve attachment factors, which bind to the particle, but do not 
lead to infection in the absence of the receptor [38]. To further complicate matters, the 
virion binding to cells might be tuned by facilitating proteins, which do not bind the 
virion, but indirectly enhance infection, for example through cell signaling and 
upregulation of the receptor levels on the cell surface [39].  
Regardless of whether a top-down or a bottom-up approach is chosen, mechanistic 
insight typically starts from correlative observations. They always incorporate different 
layers of evidence based on a robust and quantitative observation methodology. Ideally, 
they are predictive and transferable to other systems. At the molecular level, they can 
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be interrogated by interference using knock-out approaches or more subtle changes in 
the suspected molecules. A classical approach for the identification of critical host 
factors in virus infection has been genome-wide RNA interference. Initially, screens 
were conducted with unmodified double-stranded synthetic interfering RNA (siRNA) 
complementary to a given host mRNA that was knocked down through the cellular Ago-
RISC-dependent silencing complex [40]. Subsequent, screens used chemically modified 
passenger strands and 5’ overhanging nucleotides to enhance knock-down specificity 
and reduce off target effects [41]. RNAi screens were conducted against a wide range 
of virus-infected cells, including Influenza A virus, vaccinia virus, bunyavirus, 
adenovirus, herpesvirus, rhinovirus, rotavirus [42-46].  
Although off-target effects of RNAi have limited the interpretation of such screening data 
[41], the power of large-scale RNAi screens was found to be significantly enhanced by 
systematic analyses of a range of different pathogens and siRNAs with different 
chemical properties, notably in combination with a Parallel Mixed Model (PMM) 
approach to enhance the statistical power of hit detection using parallel screening [47]. 
PMM allowed the inclusion of siRNA weights that could be assigned according to 
available information on RNAi quality. Moreover, PMM enhanced the predictability of 
hits for follow-up screens through the determination of a sharedness score. This 
enabled the identification of novel hit genes involved in the entry pathway of most of the 
pathogens in the study. Recently, genetic screens were reported for cell infection with 
picornaviruses, a large family of positive-sense RNA viruses with severe impact on 
human health. In a genome-wide haploid loss-of-function screen, the phospholipase 
PLA2G16 was found to be an essential host factor for rhinovirus infection by supporting 
the translocation of the viral RNA genome from endosomes to the cytosol [48]. The 
same factor was picked up for rhinovirus infection in a genome-wide forward screen 
using a murine haplobank [49]. Arguably, although elegant, genetic loss-of-function 
screens for infection are limited to genes that are non-essential for host-cell survival. 
Computational modeling of the infection efficiency from toxic loss-of-function 
phenotypes could therefore enhance the breath of genetic haploscreens. 
Computational modeling in virology 
Logic and mathematics provide strong foundations for modeling of biological 
phenomena. Modeling is the intellectual process of formalizing knowledge about a 
system or a process. A model constitutes a hypothesis of how one believes things could 
work. Models can be extracted or learned from data or constructed from known 
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biochemical and biophysical evidence. Data-driven (also called “top-down”) models 
formalize patterns and correlations in the data that are extracted using methods from 
statistics or machine learning. Examples range from correlation analyses to 
reconstructing molecular interaction networks derived from high-content screening 
datasets [50,47] to classifying viral motion types using machine learning [24]. Data-
driven models suggest mechanisms, and can be used to show necessity of a process or 
molecule in a perturbation experiment.  
Mechanistic (or “bottom-up”) modeling aims to reconstitute a process or a system from 
known fundamental principles of chemistry and physics, such as conservation of mass 
or the statistical mechanics of chemical kinetics. Bottom-up models are akin to in vitro 
reconstitution experiments with the important difference that all system parameters can 
be controlled and the exact physics and chemistry assumed is known. As such, these 
models can be used to show sufficiency of mechanisms, which is more powerful than 
only showing sufficiency of ingredients, for example in an in vitro reconstitution [51]. 
Models of both kinds are then studied in simulations. A simulation is an experiment 
performed on a model. Computer simulations enable us to leverage the power of 
modern electronics in order to simulate models of unprecedented complexity and level 
of detail. A simulation allows any part or parameter of a model to be systematically 
perturbed or altered, and high-performance computers can simulate hundreds of 
thousands of model perturbations in a short time. Simulations also provide access to 
dynamic data, while experimentally end-point assays are often used. Using the end-
point datasets to build or identify a model that reproduces them, and then using that 
model to predict the dynamics of how the system transitioned from its starting point to 
the observed end-point, helps interpret biological information and carve out the 
essential mechanisms. 
Bridging the gap - from observations to mechanisms by computer 
simulations 
Quantitative image analysis, combined with structural and biochemical data, provides a 
wealth of information that can be used to build models of the chemical and physical 
mechanisms of infection for different viruses. The model formalizes a hypothesis. It 
captures our current understanding based on the available information. An important 
question therefore is how to validate, test, and further refine the model. One approach is 
to test if the model is necessary and sufficient to explain a process. Showing necessity 
is mostly done in perturbation experiments. If the process stops working upon knocking 
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out or altering a molecular component that is predicted to be present according to the 
model, then we know that it is necessary. Sufficiency is mostly shown in reconstitution. 
This includes in vitro reconstitution or in silico reconstitution, that is, computer 
simulation. If a reconstitution of the model, which only consists of known and controlled 
components, reproduces the correct behavior, we know that the components are 
sufficient. In simulations, not only the components but also their interactions and the 
assumed laws of physics can be freely reconstituted. Simulations therefore bridge the 
gap between observation and mechanism and show sufficiency of a mechanism by in 
silico reconstitution.    
Simulations at different levels of detail 
A rich landscape of modeling and simulation has been developed over many years, 
ranging from atoms to continua. When applied to viruses, atomistic molecular-dynamics 
simulations have mostly considered the capsid [52]. The basis for molecular-dynamics 
simulations are often high-resolution cryo-EM tomograms, for example of the HIV 
capsid [53]. These structures provide the initial placement of the atoms in the 
simulation, which then gives insight into the atomistic dynamics over time, for example 
capsid dissolution [54].  
Alternatively, simulations consider the de novo self-assembly of theoretical capsid 
structures, such as idealized polyhedral structures, and explain the thermodynamics of 
their assembly [55]. For some viruses, like tobacco mosaic virus (TMV), complete all-
atom simulations of the entire virus, including capsid and RNA have been performed 
[56]. Such all-atom molecular simulations are, however, costly and limited to short time 
scales of nanoseconds to milliseconds. The above all-atom study of TMV for example 
simulated the time-resolved dynamics of 1 million atoms over 50 nanoseconds life time. 
Studying larger entities or longer processes, such as virus entry and virus-receptor 
binding, necessitates simplifications, such as coarse-grained methods where multiple 
atoms are lumped together. For example, this approach has been used to simulate HIV 
capsid shape and investigate capsid stability [57], and to study the dynamics of several 
viral structures, including the full satellite tobacco mosaic virus (STMV) particle, the 
satellite tobacco necrosis virus (STNV) capsid, poliovirus capsid, and the reovirus core 
[58].  
Structural data derived from atomistic or coarse-grained models are often only available 
for isolated time points and do not represent the entire dynamic process, such as capsid 
assembly and maturation. The reason is that full molecular dynamics trajectories are 
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computationally too expensive to obtain. In such cases, elastic network models can be 
used to interpolate between structural states by assuming that the molecular 
constituents or coarse-grained particles are connected to each other by elastic springs. 
The so-obtained elastic structure can then be computationally morphed from one 
structural state to another, providing energetically plausible molecular trajectories. This 
approach has, for example, been used to study bacteriophage HK97 capsid maturation 
[59] and conformational changes in hepatitis C virus helicase [60]. 
Further coarse-graining models, lipid membranes can be described as continuous 
elastic sheets and viruses as rigid polyhedral arrangements of receptor binding sites. 
Such models have been used to simulate virus-receptor binding in elastic diffusive 
membranes. The corresponding simulation method, termed Brownian Reaction 
Adhesion Dynamics (BRAD), was first applied to study HIV attachment [61]. The 
approach was then extended to simian virus 40 (SV40) and compared with high-
resolution experimental data, highlighting the importance of in-membrane receptor 
diffusivity for efficient attachment of SV40 to host cells [62]. 
While such simulations are feasible for small numbers of virions, they are 
computationally intractable for large virion concentrations. Once the number of virions 
exceeds a few thousand, individual virions cannot be represented explicitly any more. In 
this case, the density or concentration field of virions is modeled as a continuous 
distribution, leading to completely continuous descriptions. This has, for example, been 
used to simulate the spreading of human adenovirus across epithelial monolayers, 
simulating what amounts to hundreds of thousands of virions and thousands of cells 
[63]. Continuous models have also been used to describe the intracellular trafficking of 
adenoviruses in host cells using diffusion-reaction-advection equations that also 
account for the intrinsic dynamics of the microtubule network [64].  
Taken together, simulations of viral structures, including capsids, envelopes, genomes, 
and surface proteins have implications for many fields of study, ranging from atomistic 
models to cell biology, imaging, and anti-viral therapeutics. Despite this importance, 
concerted community efforts of creating standardized and portable simulation software 
frameworks are scarce and as of now, have been limited to specific applications [65]. A 
generic framework of how computational modeling and wet lab experimentation 
complement each other is illustrated in Figure 1.  
Types of computational models 
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Computational models in virology can be classified along five axes – 1) discrete vs. 
continuous, 2) spatiotemporal vs. temporal, 3) stochastic vs. deterministic, 4) 
hypothesis-driven vs. data-driven, and 5) white-box vs. black-box models.  
Discrete vs. continuous models 
Examples of discrete models include atomistic and individual-virion simulations, where 
atoms or virions are modeled as discrete entities. In continuous models, the individual 
entities are not separately represented, but only their density or distribution in space 
and / or time is tracked. Continuous modeling approaches have been applied to an 
important question in virus assembly, namely, how does a virion become infectious? In 
the case of HIV, where proteolytic maturation is key to gaining virion infectivity, it has 
been hypothesized that the cleavage of the matrix (MA) domain from the envelope 
(ENV) domain (comprising the viral glycoprotein) and the spreading of MA in the virion 
allows ENV to loosen up and cluster the trimers for assembling a functional fusion 
machinery in the infectious virions [66]. Indeed, reaction-diffusion models were used to 
decouple MA from ENV, and thereby simulated an aspect of virion maturation [67]. 
Since assembly and maturation are coupled events, and the transition of immature to 
mature capsid requires conformational changes in capsid (CA), researchers also used 
coarse-grained discrete models for simulating lattice molecular assembly and non-
diffusional curling vs. de-novo assembly [68,69]. The ultimate aim here will be to 
describe the cleavage of the hetero-polymer as a cascade of events, and predict to 
what extent the cleavage has to occur in order to yield functional capsid assemblies. 
Spatiotemporal vs. temporal models 
Spatiotemporal models explicitly represent the spatial localization or distribution of 
viruses, such as done in most of the above-mentioned examples. In contrast, temporal 
models track the dynamic evolution of an aggregated quantity, such as the total virus 
load or multiplicity of infection, without reflecting its spatial localization. This is 
traditionally the case in viral kinetics models [70]. Multi-scale spatio-temporal modeling 
of virion maturation has been performed by Markov models where the free energy 
landscape of intermediate states was averaged [71]. One can expect that the 
combination of molecular dynamics and Brownian dynamics models will provide more 
computational cost-efficient simulation results.  
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Stochastic vs. deterministic models 
Another distinction is whether a model is stochastic or deterministic. In stochastic 
models, certain events happen probabilistically, such that the evolution of the infection 
state cannot be accurately predicted, but probabilities of different evolutions can be 
evaluated. For example, the infection probability of cells depends on the local virion 
concentration, and this has been implemented into a ‘white box’ model for the 
simulation of infection spread in a tissue culture model [63]. Another example for 
stochastic modeling in virus infection has been the trafficking of individual virions along 
microtubules, in an attempt to better understand the number and kind of cellular motor 
proteins involved in periods of virion motion bursts in the cytosol [72]. Stochastic 
simulations of fluorescent adenovirus particle motions involved an energy function and 
known parameters of motor stepping and on/off rates on microtubules. They predicted 
that one to two motors are bound per virion during an active motion burst. The model 
accurately reproduced the virion motions from live-cell imaging data. It predicted that 
the major capsid protein, hexon, was the receptor for the dynein/dynactin motor 
complex [72]. This notion was co-incidentally confirmed using biochemical pull-down 
and infection assays [73].  
In contrast to stochastic models, in a deterministic model all events happen with 
certainty, which typically requires complete knowledge of the molecular mechanisms at 
play. Deterministic models have been implemented for aspects of actin polymerization, 
and were extrapolated to acto-myosin-based cell motility [5,74]. Deterministic models 
might be implemented for simulating the disruption of a non-enveloped virion, where the 
interactions between capsid proteins are known in atomic detail. Such simulations 
would be informative to predict, for example, if mechanical forces acting on virus 
particles during virion drifting motions on the cell surface are sufficient for the partial 
disruption of the virion during entry, as observed in the case of adenovirus [75-
77,26,78]. The model would implement information about protein-protein contacts from 
the crystal or cryo-EM structures and the anisotropic mechanics of the icosahedral 
particle measured by atomic force microscopy [79-82]. It would inform about the force 
that is needed to pull out a capsomer at the virion vertex. Such information has high 
relevance, since the acto-myosin filaments mediating the virion drifts on the cell surface 
are much larger assemblies than the virion itself, and the minimal components of this 
machinery are unknown. How many motors, how many filaments are involved? 
Modeling might provide information about the organization of the cytosolic region 
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proximal to the plasma membrane, for example in relation to the picket–fence model 
[83].  
Hypothesis-driven vs. data-driven models 
Hypothesis-driven models are formulated based on an expectation or suspicion for 
which no data need be available at first. First, a hypothesis is formulated and then 
formalized, for example in the form of mathematical equations, rule sets, or chemical 
pathways. The resulting model is then simulated in order to study its behavior in an 
attempt to falsify the hypothesis by comparison with observations and known facts.  
Alternatively, models can be learned from data without formalizing a hypothesis. This is 
often useful in the initial exploratory phase of a study, or when seeking higher-order 
patterns in data that are not apparent to the human observer. While methods of 
statistical analysis have done precisely this for a long time, recent breakthroughs in 
machine learning and artificial intelligence have brought a new quality to data-driven 
modeling. Modern machine-learning methods, such as deep and convolutional neural 
networks, are exceedingly powerful at discovering patterns in complex datasets. As they 
are not hypothesis-driven, they do not directly serve the purpose of showing a biological 
mechanism, but they uncover correlations and open the possibility to classify previously 
unseen data. Supervised machine-learning requires large amounts of training data from 
known conditions in order to learn the correlations. Therefore, it is not surprising that 
some of the first applications in virology were in detecting correlations of host-cell gene 
expression levels with viral infection status, for example in hepatitis B virus infections 
[84].  
Another application where training data are typically available is in single-virion tracking 
experiments. Using automated tracking software [23], hundreds or thousands of 
trajectories can be automatically extracted from large image datasets and different 
motion patterns can be labeled by hand. From these training data, a supervised 
machine-learning method can then learn the descriptive features of the motion patterns 
and predict them in new trajectories as well [24]. A third example of a successful 
application of machine-learning to virology is the discovery how cell-to-cell variability 
influences virus infection by endocytosis [85]. This was made possible by analyzing 
large sets of high-content screening images and learning models that link the cellular 
context in an image to the observed infection dynamics.  
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White box vs. black box models 
Models are also classified according to the number of free parameters they have, which 
typically are fitted to experimental data. White-box models have no or just a few 
unknown parameters. A white-box model is the most direct evidence for sufficiency of a 
mechanism. If, for example, all diffusion constants, infection probabilities, and binding 
affinities are independently measured, and the model recapitulates the data, this is 
strong evidence that the modeled mechanisms are sufficient. In contrast to white-box 
models, black-box models are entirely identified by parameter fitting. They therefore 
provide indirect ways of estimating quantities that are not directly measurable or 
observable once the basic mechanism is known. They do, however, always leave some 
ambiguity about the actual mechanism, as different mechanisms could recapitulate the 
same data for different parameter values.  
Enabling statistical inference 
An important role of simulations is to enable statistical inference from experimental data. 
Inference is typically done in either the maximum-likelihood framework or the Bayesian 
framework. Both require a “forward model” of the observation process. Assume, for 
example, that one would like to infer how the morphology of endosomes changes upon 
virus entry. Since the question is about dynamics, live imaging is desirable. Light 
diffraction, however, limits the details visible in the images, especially when observing 
small structures like endosomes [29]. Using a simulation to model the image-formation 
process in the microscope, however, one can robustly infer the time-resolved 
endosomal shape that is most probable to have created the observed image [86]. 
Likewise, a simulation of virus plaque formation in infected tissues can be used to infer 
the mechanism of virus spread that is most likely to lead to the observed plaque 
dynamics [63]. 
Extracting information from merged heterogeneous complex data 
Increasingly, viral processes are studied by combining different sources of data, such as 
fluorescence microscopy, electron microscopy, biochemical assays, infection assays in 
tissue culture, structural data, and epidemiological data. These data are heterogeneous, 
as they come in different forms, such as images, numbers, graphs, and time series. 
Merging complex heterogeneous data in order to extract information from them usually 
requires a computer model of the studied process. The simulation environment provides 
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a uniform container into which all data types can be fused, as long as they can be 
computationally handled.  
Aiding experimental design 
Simulation models almost always contain parameters, such as diffusion constants, 
reaction rates, or binding affinities. While some of them can be measured 
experimentally, it is usually undesirable to blindly measure all of them. Instead, one 
wishes to focus experimentation on parameters that are important to the overall 
behavior of the model. Once a simulation of the model is available, global sensitivity 
analysis methods [87] can be used to determine parameter importance. Experimental 
measurements or perturbations can then focus on those parameters that are predicted 
to be important for the function of the modeled process. At the same time, parameters 
that turn out to have little or no influence on the model behavior can be removed from 
the model, hence simplifying the model. Models thus become evolving hypotheses that 
suggest both next experiments and iterative refinements by incorporating the 
experimental results. 
Fitting the values of unknown parameters by design centering 
Data fitting is the standard approach to using a model to infer unknown values of, for 
example diffusion constants or reaction rates [88]. Almost invariably, the task of model 
fitting is formulated as an optimization problem. This is to find the parameter values, for 
which the model output is as close as possible to the experimentally measured data. 
However, optimal fitting can be dangerous for two reasons: First, the model necessarily 
is an incomplete approximation to reality and the experimental data include unknown 
measurement uncertainties. The best fit of one to the other is not necessarily the most 
meaningful in reality. Second, optimizing the fit may lead to models of growing 
complexity that reproduce intricate details or trace meaningless measurement errors, 
obscuring the basic mechanism. This is known as overfitting in machine-learning 
approaches.  
Instead of formulating parameter inference as an optimization problem, it can be 
formulated as a design-centering problem. Design centering is a classic problem in 
engineering, first described in the electronics community [89]. In design centering, one 
specifies criteria that define a good model. These criteria can for example be that all 
measurements are matches within 1% error, and all concentrations have positive 
values. Any set of parameter values for which the model fulfills these criteria 
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corresponds to an acceptable model, of which there are usually many. Design centering 
now finds the one model/parameters that are acceptable and have maximal robustness 
against random fluctuations in the data or the parameters. That is, the final model has 
the highest probability of still being acceptable for the next, yet unseen experiment and 
slight changes in the parameters only minimally alter its behavior.  
Since design centering finds robust models that fit ‘well enough’, it is free of overfitting 
and naturally generalizes across experimental conditions. Particularly in virology this 
viewpoint intuitively makes sense, since the robustness of an infection mechanism 
against, for example changing immune response and changes in the biophysical 
parameters of the cell is evolutionarily selected for. It is thus expected that design-
centered mechanisms have higher chances of surviving and are thus more likely to be 
true. Importantly, design-centering can therefore also be used to select between 
different competing models and choose the more likely one, since it naturally quantifies 
the robustness of a model.  
Despite its advantages, design-centering is only rarely used. The reason is the high 
computational cost it incurs. In fact, design centering has been proven to be non-
deterministic polynomial (NP)-hard, which means that it is impossible to be solved 
efficiently on a deterministic computer [90]. Recently, however, the first efficient 
approximation algorithm for general design-centering problems has become available 
[91]. This procedure may replace optimization when fitting model parameters to data, 
ultimately leading to more robust models that account for measurement uncertainties 
and that are evolutionarily plausible.  
Modeling influenza A virus (IAV) 
With regards to enveloped viruses, emerging experimental data from lipidome analyses, 
together with cryo-EM structures have motivated computational efforts to generate 
glycolipid-protein interaction maps, and to explore if a particular protein of the virion 
envelope is directly exposed to the environment and might hence present a direct drug 
target [92]. Mapping of the potential impact of the glycan residues on the viral 
glycoproteins might inform about the shielding of particular antigenic sites, with a 
possible impact on antigenic variation influenced by the kind and extent of glycosylation, 
which is a key issue in the design of effective vaccines against influenza virus.  
With respect to IAV, an interesting regulatory protein is the M2 ion channel. M2 is a 
homo-tetrameric protein with a single transmembrane segment each. It is present in the 
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virion envelope and in membranes of the secretory and endocytic pathways of infected 
cells. M2 is well known for its proton conductance [93-95]. It is widely conserved among 
IAV, indicative of important function in the viral life cycle. In fact, if the M2 channel is 
blocked by drugs, such as amantadine, virus entry is inhibited [96]. In absence of 
amantadine, the interior of the virion acidifies when located in a low-pH endosomal 
compartment, and the ribonucleoprotein (RNP) complexes dissociate from the capsid-
coat protein M1 [97,94,98,99]. Modeling enabled elucidating the mechanism of proton 
conductance, involving histidine imidazole-imidazole stabilization of the charge in the 
lipid bilayer [100]. The tetrameric nature of the M2 channel thereby helps distribute the 
positive charge across different histidine residues, and thereby helps minimize a futile 
cycle in order to favor the productive cycle of proton conductance.  
IAV rapidly evolves resistance against amantadine, and modeling again helped explain 
how this is possible. Using molecular dynamics simulations, it has been found that a 
single point-mutation (Ser31Asn) in M2 rendered IAV resistant to the M2-channel 
blocker amantadine [101]. Surprisingly, amantadine still bound to the S31N mutant of 
M2, more flexibly than in the wild-type channel, in which it stably binds to the plugging 
region [102]. In the mutant configuration, water surrounding the drug can easily 
transport protons past the plugging drug, thereby explaining proton transport even with 
the drug bound to M2. This sufficient mechanism has later been confirmed by a 
combination of nuclear magnetic resonance (NMR) experiments and simulation data 
using rimantadine, an anti-viral compound structurally related to amantadine [103]. 
By neutralizing the pH in acidic cellular compartments, M2 also subverts the normal 
function of endosomes and of the Golgi apparatus, and it inhibits premature 
conformational changes in the newly synthesized viral HA protein in the Golgi. During 
virion budding from the plasma membrane, M2 replaces the ESCRT (endosomal sorting 
complexes required for transport) machinery by localizing to curved membrane 
domains. In simulations reconstituting the action of the M2 channel in membrane 
budding, an excess of lipid moieties was necessary for obtaining a reliable 
representation of viral budding, due to the wedging effects of M2 and lipid bilayer 
curvature [100].  
Besides conducting protons, M2 is thought to also conduct Na+ and K+ ions [104-106]. 
This feature is important for virion uncoating and infection, as shown in acid-bypass 
experiments where extracellular IAV particles attached to the plasma membrane gained 
infectivity when exposed to millimolar extracellular concentrations of K+ [107]. Na+ and 
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K+ conductance through M2 is possible, despite the clear preference that M2 has for H+ 
over Na+ [108]. The reason why this is possible is that the concentrations of Na+ or K+ in 
endo-lysosomes are 5 to 6 orders of magnitude higher than the proton concentration 
[109]. In liposome reconstitution assays, M2 was shown to be slightly permeable to Na+ 
and K+ [102]. Thus, it is possible that H+, Na+ and K+ have similar fluxes across M2 
when the virion is in an acidified endosome. Since the virion is in a Na+-rich 
environment when infecting cells from the outside, it will be particularly interesting to 
model the flux of K+ across M2 as a function of the K+ concentration, and to simulate 
possible effects of K+ on the M1-RNP interactions or other components of the virion 
lumen, such as the viral RNA-dependent RNA polymerase. 
Outlook 
Computational methods have come a long way in virology. They range from now-
standard computational image analysis, such as single-virion tracking [23], to machine-
learning approaches for automated model extraction [24], and to identifying predictive 
interaction potentials between virions and host-cell compartments from images [30]. 
Many of these developments were inspired by applications in virology in the first place, 
rendering it a truly interdisciplinary effort. Computer simulations of learned or 
hypothesized models enable in silico reconstitution, and can show sufficiency of a 
mechanism, rather than just of a list of ingredients or molecules. Simulations can be 
done at different levels of resolution, from all-atom molecular dynamics simulations to 
continuum models.  
On the molecular scale, it seems obvious to take advantage of the increasingly detailed 
structural information on inter-atomic contacts in order to model viral capsid mechanics. 
Discrete mechanical assembly models can be compared with continuum thin-shell 
descriptions in order to disentangle stochastic and deterministic mechanisms. 
Eventually, this may lead to the simulation of conformational changes in virus particles, 
as for example triggered by uncoating cues [110,38,111]. In a next step, the interaction 
of the exposed membrane-active viral proteins with host-cell membranes can be 
modeled using a coarse-gained approach. This could be rewarding, and inform about 
how higher-order oligomers lead to enhanced ability to disrupt membranes, for example 
by recruiting additional monomers from the surface without a kinetic barrier of 
membrane insertion for the additional monomers. Such mechanism has been proposed 
for the disruption of bacterial membranes by antimicrobial peptides [112]. It could have 
implications on the mechanism of viral membrane rupturing proteins, such as protein VI 
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of the human adenovirus, which preferentially binds to and disrupts ceramide-rich lipid 
bilayers [113,114]. We anticipate that depending on the oligomer formed, these 
membrane-active peptides make different sized channels, which can be measured by 
various sized dextrans, or thermodynamically disrupt the membrane as proposed for 
antimicrobial peptides. Experiments could be complemented by continuum simulations 
of membrane leakage. In addition, structural virion information can be used for 
predictive modeling of flexible regions of a virion, including intrinsically disordered 
domains on the surface of the particle. These regions are prone to interact with many 
different proteins in unpredictable manners, and often represent antigenic sites for the 
binding of neutralizing antibodies. Including these effects would greatly enhance the 
currently rather crude multi-scale models of virion attachment and in-membrane 
receptor diffusion [61,62].  
Despite exciting prospects, we are aware of the difficulty and the challenges in modeling 
biological phenomena, including viruses. In this regard, we would agree with George 
Edward Pelham Box that ‘all models are wrong, but some are useful’, and knowing this 
with Richard Feynman – ‘it is much more interesting to live not knowing than to have 
answers which might be wrong.’ 
 
Figure 1: An integrative modeling and wet-lab approach towards mechanisms of 
infection biology 
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